HCA — HCA Healthcare, Inc.

HCA Healthcare Q3 2025 Earnings Call Summary

1. Key Financial Results and Metrics

• Earnings Per Share (EPS): Increased by 42% year-over-year (YoY) on a diluted basis.
• Revenue: Grew by 9.6% YoY, driven by volume growth, improved payer mix, and Medicaid supplemental programs.
• Same Facility Equivalent Admissions: Increased by 2.4% YoY.
• Surgical Volume: Inpatient surgical volume up 1.4%, outpatient surgical volume up 1.1%.
• Adjusted EBITDA: Increased significantly, with a notable $240 million benefit from Medicaid supplemental payments.
• Cash Flow from Operations: Reported at $4.4 billion, with $1.3 billion in capital expenditures and $2.5 billion in share repurchases.
• Updated Full-Year Guidance: Revenue expected between $75 billion and $76.5 billion, with adjusted EBITDA between $15.25 billion and $15.65 billion.

2. Strategic Updates and Business Highlights

• Operational Excellence: Continued focus on enhancing care quality, patient access, and operational efficiency through investments in digital tools and staff training.
• Resiliency Program: Ongoing efforts to improve operational efficiency and financial resilience, with a target of $600 million to $800 million in savings.
• Payer Mix Improvement: Notable growth in commercial admissions (up 3.7%) and Medicare (up 3.4%), while Medicaid and self-pay volumes declined.
• Outpatient Facilities: Expansion of outpatient services and improved operational capabilities to enhance patient care and service delivery.

3. Forward Guidance and Outlook

• 2026 Preliminary Outlook: Anticipates continued solid demand for healthcare services, with volumes expected to grow within the long-term range of 2% to 3%.
• Cost Stability: Operating costs expected to remain stable, with some pressures in specific areas.
• Capital Allocation: Plans to maintain a disciplined approach to capital deployment, focusing on long-term value creation.

4. Bad News, Challenges, or Points of Concern

• Declining Medicaid and Self-Pay Volumes: Both categories saw declines, which may impact future revenue growth.
• Hurricane Impact: Continued challenges in hurricane-affected markets, particularly in North Carolina, with lingering effects on payer mix and staffing costs.
• Professional Fees: Increased by 11% YoY, driven by anesthesia and radiology, indicating rising operational costs.
• Regulatory Risks: Uncertainty surrounding the extension of enhanced premium tax credits and potential impacts on coverage for millions of Americans.

5. Notable Q&A Insights

• Medicaid Supplemental Payments: Discussions around pending state approvals for grandfathered programs, with states like Florida, Georgia, and Virginia still under review.
• Elective Procedures: Potential uptick in elective surgeries anticipated in Q4 due to concerns over coverage changes among patients.
• Hurricane Recovery: Expected to recover $100 million of the $250 million EBITDA headwind from hurricanes in 2025, with further guidance on recovery anticipated in the next earnings call.
• AI and Technology: Ongoing investments in AI for revenue cycle management and documentation to improve operational efficiency and reduce denial rates.

Overall, HCA Healthcare reported strong financial performance in Q3 2025, with positive growth metrics and strategic initiatives aimed at enhancing operational resilience, despite facing challenges in certain areas such as Medicaid volumes and hurricane recovery. The company remains optimistic about its future outlook and ability to navigate regulatory uncertainties.